See every side of every news story

Published 9 days ago • loading... • Updated 9 days ago

iFabric Announces Publication of Groundbreaking Clinical Trial Proving the Infection Control Ability of Protx2(R) And Ecopel(TM) Treated Scrubs

Summary by Hastings Tribune

MARKHAM, ON / ACCESS Newswire / August 19, 2025 / iFabric Corp. (TSX:IFA)(OTCQX:IFABF), is pleased to announce that the results of its clinical trial, "Antimicrobial-treated fabric scrubs can prevent pathogen proliferation on scrubs", has been officially published in the Journal…

1 Articles

1 Articles

Hastings Tribune

iFabric Announces Publication of Groundbreaking Clinical Trial Proving the Infection Control Ability of Protx2(R) And Ecopel(TM) Treated Scrubs

MARKHAM, ON / ACCESS Newswire / August 19, 2025 / iFabric Corp. (TSX:IFA)(OTCQX:IFABF), is pleased to announce that the results of its clinical trial, "Antimicrobial-treated fabric scrubs can prevent pathogen proliferation on scrubs", has been officially published in the Journal…

9 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left0Leaning Right0Center1Last Updated9 days agoBias Distribution

100% Center

Bias Distribution

100% of the sources are Center

100% Center

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Hastings Tribune broke the news in 9 days ago on Tuesday, August 19, 2025.

Sources are mostly out of (0)

Similar News Topics

Stories disproportionately reported by the Left or the Right

Similar News Topics